NASDAQ:SLGL Sol-Gel Technologies (SLGL) Stock Price, News & Analysis $28.00 +4.60 (+19.66%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$27.26 -0.75 (-2.66%) As of 09/4/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Sol-Gel Technologies Stock (NASDAQ:SLGL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sol-Gel Technologies alerts:Sign Up Key Stats Today's Range$22.67▼$28.9950-Day Range$7.01▼$28.0052-Week Range$4.01▼$28.99Volume51,474 shsAverage Volume30,610 shsMarket Capitalization$78.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. Read More Sol-Gel Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreSLGL MarketRank™: Sol-Gel Technologies scored higher than 29% of companies evaluated by MarketBeat, and ranked 784th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Sol-Gel Technologies. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Sol-Gel Technologies are expected to decrease in the coming year, from ($0.28) to ($0.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sol-Gel Technologies is -22.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sol-Gel Technologies is -22.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSol-Gel Technologies has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Sol-Gel Technologies' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.47% of the float of Sol-Gel Technologies has been sold short.Short Interest Ratio / Days to CoverSol-Gel Technologies has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sol-Gel Technologies has recently decreased by 36.60%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSol-Gel Technologies does not currently pay a dividend.Dividend GrowthSol-Gel Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.47% of the float of Sol-Gel Technologies has been sold short.Short Interest Ratio / Days to CoverSol-Gel Technologies has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sol-Gel Technologies has recently decreased by 36.60%, indicating that investor sentiment is improving significantly. News and Social Media3.2 / 5News Sentiment0.73 News SentimentSol-Gel Technologies has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Sol-Gel Technologies this week, compared to 0 articles on an average week.Search Interest6 people have searched for SLGL on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat Follows1 people have added Sol-Gel Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Sol-Gel Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders66.51% of the stock of Sol-Gel Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 26.18% of the stock of Sol-Gel Technologies is held by institutions.Read more about Sol-Gel Technologies' insider trading history. Receive SLGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLGL Stock News HeadlinesSol-Gel Announces Health Canada Approval of EPSOLAY®September 4 at 6:35 PM | finance.yahoo.comSol-Gel Technologies announces Health Canada approval of EPSOLAYSeptember 4 at 6:35 PM | msn.com“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning. | InvestorPlace (Ad)Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 240% return over the last yearSeptember 4 at 6:35 PM | finance.yahoo.comSol Gel Technologies trading halted, volatility trading pauseAugust 22, 2025 | msn.comSol-Gel Stock Delivers Over 150% Gain - Can The Upcoming Q4 Clinical Data Readout Sustain The Rally? August 21, 2025 | rttnews.comSol-Gel Technologies Reports Strong Q2 2025 ResultsAugust 20, 2025 | msn.comSol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatesAugust 15, 2025 | globenewswire.comSee More Headlines SLGL Stock Analysis - Frequently Asked Questions How have SLGL shares performed this year? Sol-Gel Technologies' stock was trading at $9.3010 at the beginning of 2025. Since then, SLGL shares have increased by 201.0% and is now trading at $28.00. How were Sol-Gel Technologies' earnings last quarter? Sol-Gel Technologies Ltd. (NASDAQ:SLGL) released its earnings results on Friday, August, 15th. The company reported $4.17 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.67) by $4.84. The company had revenue of $17.26 million for the quarter, compared to the consensus estimate of $2.86 million. Sol-Gel Technologies had a negative trailing twelve-month return on equity of 11.80% and a negative net margin of 14.25%. When did Sol-Gel Technologies' stock split? Sol-Gel Technologies's stock reverse split before market open on Monday, May 5th 2025.The 1-10 reverse split was announced on Thursday, May 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 2nd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Sol-Gel Technologies IPO? Sol-Gel Technologies (SLGL) raised $60 million in an initial public offering on Thursday, February 1st 2018. The company issued 5,000,000 shares at $11.00-$13.00 per share. Jefferies and BMO Capital Markets acted as the underwriters for the IPO and JMP Securities and Raymond James were co-managers. Who are Sol-Gel Technologies' major shareholders? Top institutional shareholders of Sol-Gel Technologies include Phoenix Financial Ltd. (17.71%), Yelin Lapidot Holdings Management Ltd. (0.64%) and Raymond James Financial Inc. (0.38%). How do I buy shares of Sol-Gel Technologies? Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sol-Gel Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sol-Gel Technologies investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), ADMA Biologics (ADMA) and Fortress Biotech (FBIO). Company Calendar Last Earnings8/15/2025Today9/04/2025Next Earnings (Estimated)11/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - GENERIC DRG Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:SLGL CIK1684693 Webwww.sol-gel.com Phone(728) 931-3433Fax972-153-523044444Employees50Year Founded1997Profitability EPS (Trailing Twelve Months)($1.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.58 million Net Margins-14.25% Pretax Margin-14.25% Return on Equity-11.80% Return on Assets-9.39% Debt Debt-to-Equity RatioN/A Current Ratio7.32 Quick Ratio7.32 Sales & Book Value Annual Sales$11.54 million Price / Sales6.77 Cash FlowN/A Price / Cash FlowN/A Book Value$11.44 per share Price / Book2.45Miscellaneous Outstanding Shares2,790,000Free Float933,000Market Cap$78.12 million OptionableOptionable Beta1.26 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:SLGL) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.